Skip to main content
. 2023 Jun 15;14:1175237. doi: 10.3389/fendo.2023.1175237

Table 1.

Patient characteristics.

Non-re-PTx group
n = 709
Re-PTx group
n = 61
P value OR 95% CI
Sex (male), n (%) 403 (56.8) 34 (55.7) 0.867 0.956 0.565 1.619
Age (years), mean (SD) 55.3 (11.4) 54.0 (12.3) 0.450
Height (cm), mean (SD) 160.8 (9.5) 161.8 (10.4) 0.495
Body weight (kg), mean (SD) 58.0 (13.1) 57.7 (11.2) 0.727
Body mass index (kg/m2), mean (SD) 22.3 (3.7) 22.0 (3.2) 0.756
Dialysis vintage (months), mean (SD) 145.5 (96.8) 111.2 (48.6) 0.003
Diabetic nephropathy, n (%) 78 (11.0) 3 (4.9) 0.190 0.418 0.128 1.367
Preoperative vitamin D receptor activation therapy, n (%) 533 (75.2) 42 (68.9) 0.116 0.635 0.359 1.123
Preoperative calcimimetic therapy, n (%) 216 (30.5) 14 (23.0) 0.245 0.678 0.366 1.259
Preoperative serum albumin level (g/dL), mean (SD) 3.6 (0.5) 3.5 (0.5) 0.082
Preoperative serum alkaline phosphatase level (U/L), mean (SD) 451.3 (428.4) 447.0 (357.8) 0.874
Preoperative serum calcium level (mg/dL), mean (SD) 10.0 (0.8) 10.2 (0.6) 0.008
Preoperative serum calcium level corrected by serum albumin level (mg/dL), mean (SD) 10.4 (0.9) 10.8 (0.8) 0.003
Preoperative serum phosphorus level (mg/dL), mean (SD) 6.2 (4.5) 6.6 (1.6) 0.009
Serum intact PTH level at admission (pg/mL), mean (SD) 882.3 (559.9) 998.9 (515.2) 0.027

CI, confidence interval; OR, odds ratio; PTH, parathyroid hormone; PTx, parathyroidectomy; SD, standard deviation.

Bold font indicates statistically significant results.